These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2877894

  • 1. Low-dose infusion of somatostatin in man--no effect upon intestinal calcium absorption but a fall in blood insulin.
    Rümenapf G, Hanisch E, Schwille PO.
    Exp Clin Endocrinol; 1986 Aug; 87(3):306-12. PubMed ID: 2877894
    [Abstract] [Full Text] [Related]

  • 2. Effects of acutely infused pentagastrin and somatostatin on intestinal calcium absorption in humans.
    Scholz D, Schwille PO.
    Miner Electrolyte Metab; 1982 Feb; 7(2):76-85. PubMed ID: 6133213
    [Abstract] [Full Text] [Related]

  • 3. Effects of gastrin and secretin on intestinal calcium absorption in the rat.
    Rümenapf G, Beer T, Meyer E, Schwille PO.
    Clin Physiol Biochem; 1990 Feb; 8(6):333-40. PubMed ID: 1983423
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and effects of intravenous infusion of somatostatin in normal subjects--a two-compartment open model.
    Ho LT, Chen RL, Chou TY, Fong JC, Wang PS, Chou CK.
    Clin Physiol Biochem; 1986 Feb; 4(4):257-67. PubMed ID: 2875821
    [Abstract] [Full Text] [Related]

  • 5. Effect of somatostatin in the Syrian hamster bearing a transplantable islet-cell tumor.
    Luyckx AS, Lefebvre PJ.
    Horm Metab Res; 1978 Mar; 10(2):105-10. PubMed ID: 206496
    [Abstract] [Full Text] [Related]

  • 6. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS, Ho LT.
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [Abstract] [Full Text] [Related]

  • 7. The effect of somatostatin on fasting and postprandial plasma GIP, serum insulin, and blood glucose in man.
    Jorde R, Waldum HL, Burhol PG, Lygren I, Schulz TB, Florholmen J, Jenssen TG.
    Scand J Gastroenterol; 1981 Jun; 16(1):113-9. PubMed ID: 6112787
    [Abstract] [Full Text] [Related]

  • 8. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE, Lorenzi M, Bier DM, Tsalikian E, Schneider V, Karam JH, Forsham PH.
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [Abstract] [Full Text] [Related]

  • 9. Antidiabetic action of somatostatin after oral glucose loading: due to suppression of glucagon and growth hormone or of intestinal carbohydrate absorption?
    Bratusch-Marrain P, Vierhapper H, Grubeck-Loebenstein B, Waldhäusl W, Nowotny P.
    Horm Metab Res; 1981 Jun; 13(6):305-9. PubMed ID: 6114914
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA, Cryer PE, Gerich JE.
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [Abstract] [Full Text] [Related]

  • 12. Rate dependent stimulation of insulin and glucagon but not gastrin and somatostatin release during the intestinal phase of a meal.
    Schusdziarra V, Dangel G, Henrichs I, Klier M, Pfeiffer EF.
    Horm Metab Res; 1982 Apr; 14(4):169-71. PubMed ID: 6123480
    [Abstract] [Full Text] [Related]

  • 13. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
    Berelowitz M, Kronheim S, Pimstone B, Shapiro B.
    J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
    [Abstract] [Full Text] [Related]

  • 14. Exogenous somatostatin raises plasma insulin levels in patients with insulin-dependent diabetes mellitus.
    Kollind M, Moberg E, Lins PE, Adamson U.
    Horm Metab Res; 1990 Nov; 22(11):581-3. PubMed ID: 1980258
    [Abstract] [Full Text] [Related]

  • 15. Response of plasma somatostatin-like immunoreactivity to the administration of alloxan in dogs.
    Schusdziarra V, Harris V, Unger R.
    Horm Metab Res; 1979 Aug; 11(8):457-9. PubMed ID: 499995
    [Abstract] [Full Text] [Related]

  • 16. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
    Villaume C, Beck B, Kolopp M, Toussain P, Debry G.
    Biomed Pharmacother; 1986 Aug; 40(2):61-4. PubMed ID: 2875745
    [Abstract] [Full Text] [Related]

  • 17. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L, Sherwin R, Hendler R, Felig P.
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [Abstract] [Full Text] [Related]

  • 18. The influence of somatostatin on the absorption of triglycerides in partially gastrectomized subjects.
    Hengl G, Prager J, Pointner H.
    Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):392-5. PubMed ID: 525216
    [Abstract] [Full Text] [Related]

  • 19. Circadian variations of plasma somatostatin levels in healthy subjects.
    Strazzulla G, Guazzelli R, Romano S, Matassi L, Cotrozzi G, Brocchi A.
    Chronobiologia; 1990 Oct; 17(3):219-25. PubMed ID: 1977563
    [Abstract] [Full Text] [Related]

  • 20. Effect of nicotinic acid on plasma glucose concentration in normal individuals.
    Landau C, Chen YD, Skowronski R, Hollenbeck CB, Jaspan JB, Reaven GM.
    Horm Metab Res; 1992 Sep; 24(9):424-8. PubMed ID: 1358776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.